“borderline significant”

VGF showed a different pattern with evidently lower values in patients with AD dementia than in control subjects (β = −0.46 [SE 0.19]) and in patients with MCI (−0.93 [SE 0.22]), whereas the difference between patients with MCI and control subjects was only borderline significant (β = 0.47 [SE 0.20], p = 0.05).

The final multivariate multiple regression model for veterinarians’ design preferences identified one borderline significant association ( P = 0.05; 1 − Wilks’ lambda = 0.13) between the covariate describing whether veterinary practices were also servicing pig herds and veterinarians’ relative preference of program attributes.

Age was a borderline significant predictor ( p = 0.05).

However, when the left ventricular mass was indexed relative to the BSA, the difference between groups was only borderline significant ( p = 0.05).

Controlling for average distance to health facility, number of antenatal care visits, education of women, and parity, planning to save money was associated with giving birth with the assistance of a skilled provider, although the association was borderline significant (p=0.05).

Importantly, the Charlson Comorbidity Index showed a borderline significant association with longer antibiotic duration (β = 4.57, 95% CI: −0.05 to 9.20, p = 0.05). 3.6.

Secondary analyses to examine the dose–response relationship between cognitive function and IL-6 showed MoCA quintiles to be a borderline significant predictor of cortisol AUC responses after surgery ( β = −0.176, CI = −906.318–−0.370, p = 0.050) after controlling for covariates.

Notably, these associations remained robust after further adjustment for clinical and SES variables, except that telomere length reduction remained borderline significant after SES adjustment (−68.4 bp, 95% CI −113.1 to −5.7; p=0.05).

The borderline significant effect of FSE on RMS5 at 7.00 mm ( p = 0.050) was unexpected, as FSE primarily targets spherical aberration (Z4 0 ) rather than fifth-order terms.

There was a borderline significant difference in p[Na] following the intervention from baseline to visit 6 for the intervention group (p = 0.050).

Moreover, in a prospective randomized, double-blind, placebo-controlled trial enrolling 106 patients with both NAFLD and T2DM who were assigned to receive empagliflozin 10 mg ( n = 35), pioglitazone 30 mg ( n = 34), or placebo ( n = 37) for 24 weeks, only a borderline significant decrease in CAP score was observed with empagliflozin compared with placebo (−29.6 dB/m (−39.5 to −19.6) vs. −16.4 dB/m (−25.0 to −7.8), respectively; p = 0.05) [ 39 ].

Age showed a borderline significant link with mortality (p=0.05), suggesting a slight risk increase with age.

Specifically, as exhibited in Figure 2 , the analyses of the three-way conditional effect ( B = 0.16; p < 0.05) showed that the interaction between role ambiguity and transformational leadership regarding job satisfaction was significant among respondents holding a position as a supervisor/manager ( B = 0.23; p < 0.001), but only borderline significant among respondents not holding a supervisor/manager position ( B = 0.07, p ≤ 0.05).

More frequent kennel pacing in placebo group kittens was borderline significant during the SS3 time point ( P = 0.05).

Post hoc t -tests showed no difference between MDD and HC before treatment ( t (62) = −0.46, p = 0.644, Cohen’s d = 0.11), but a borderline significant difference after treatment ( t (62) = 1.99, p = 0.050, Cohen’s d = 0.51).

While building the multivariable predictive model for SD, we found that diabetes was borderline significant with a negative association ( p = 0.05), even though it was not significant in univariable comparisons ( p = 0.94).

This yielded an AUC.64 for concentration, which was borderline significant ( p =.05).

However, there was a borderline significant sex-difference (P = 0.05) in the association between EPA and AO; and EPA was associated with AO (P = 0.03), SAD (P = 0.03), and WC (P = 0.02) in women, when evaluated in sex-specific analyses using multivariable-adjusted models ( S2 and S3 Tables).

This study found that patients with CeD, younger-onset diabetes, MS, asthma, and SLE were at higher risk of ALS, and the rate ratio for UC was borderline significant ( P = 0.05), and no significant difference was found for RA, psoriasis and CD.

Baseline IL-6 ( Table 4 , down) showed a borderline significant positive association with attention at baseline (TMT-A: β = 0.360, p = 0.050), which persisted as a trend at 5 years (β = 0.996, p = 0.052) and reached significance at 10 years (β = 0.568, p = 0.020).

For progression to NV, a similar effect of BMI for type 1 carriers versus noncarriers was not seen: the effect of BMI among carriers was not significant (OR = 0.6; 95% CI = 0.2, 1.9; P = 0.33), whereas it was borderline significant among noncarriers (OR = 1.2; 95% CI = 1.0, 1.4; P = 0.05).

Evaluation of systemic markers of inflammation (hs-CRP, IL-6, IL-8 and fibrinogen) only revealed a borderline significant decrease in plasma hs-CRP concentration after doxycycline treatment (−0.51 μg/ml, P =0.050; Table 3 ).

Improvement in work and social functioning was borderline significant (mean change −2.92, Hedges g = 0.28; P = 0.05).

Multiple logistic regression analysis of the remaining predictors, including anti-dsDNA, C4, ESR, and clinically detected synovitis, showed clinically detected synovitis had the most significant association with and the highest odds of US-detected inflammatory arthritis in the final model (aOR = 142.35, 95% confidence interval [CI] 6.55–3093.96; p = 0.002), as well as a borderline significant association with ESR levels (aOR = 1.04, 95% CI 1.00–1.08; p = 0.05).

There was a significant fibrosis‐adjusted treatment effect for TPIP vs placebo of 3.8% (P = 0.02) onBV5A‐PR and a borderline significant fibrosis‐adjusted treatment effect for TPIP vs placebo of 6.4% (P = 0.05) onBV5A‐PRA.